Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan

Published:2011-07 Issue:5 Volume:14 Page:647-651
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Hsu Tzu-Chi,Chen Hong-Hwa,Yang Ming-Chin,Wang Hwei-Ming,Chuang Jye-Hann,Jao Shu-Wen,Chiang Hsin-Chieh,Wen Chung-Yu,Tseng Jen-Hao,Chen Li-Tzong

Funder

Roche

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference19 articles.

1. Colorectal cancer screening: its time for action in Asia;Sung;Cancer Detect Prev,2007

2. Vital Statistics Annual Report,2006

3. Bureau of National Health Insurance of Taiwan,2006

4. Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up;Van Cutsem;Ann Oncol,2007

5. Incidence and patterns of recurrence following curative resection for colorectal carcinoma;Obrand;Dis Colon Rectum,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review;Cost Effectiveness and Resource Allocation;2023-01-31

2. Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine–Based Chemotherapy in Patients With Early-Stage Colon Cancer;Clinical Colorectal Cancer;2021-12

3. The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review;Medical Decision Making;2021-10-25

4. Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population‐based study;The International Journal of Health Planning and Management;2021-09-20

5. Health Technology Assessment Challenges in Oncology: 20 Years of Value in Health;Value in Health;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3